Krynica Vitamin S.A. (WSE:KVT)

Krynica Vitamin Statistics

Total Valuation

Krynica Vitamin has a market cap or net worth of PLN 122.52 million. The enterprise value is 155.72 million.

Market Cap	122.52M
Enterprise Value	155.72M

Important Dates

The last earnings date was Thursday, September 25, 2025.

Earnings Date	Sep 25, 2025
Ex-Dividend Date	Jul 10, 2025

Share Statistics

Krynica Vitamin has 12.25 million shares outstanding.

Current Share Class	12.25M
Shares Outstanding	12.25M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	0.09%
Owned by Institutions (%)	1.92%
Float	1.61M

Valuation Ratios

The trailing PE ratio is 8.43.

PE Ratio	8.43
Forward PE	n/a
PS Ratio	0.32
PB Ratio	1.25
P/TBV Ratio	1.30
P/FCF Ratio	6.14
P/OCF Ratio	4.21
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 4.22, with an EV/FCF ratio of 7.81.

EV / Earnings	10.71
EV / Sales	0.40
EV / EBITDA	4.22
EV / EBIT	6.80
EV / FCF	7.81

Financial Position

The company has a current ratio of 0.94, with a Debt / Equity ratio of 0.50.

Current Ratio	0.94
Quick Ratio	0.59
Debt / Equity	0.50
Debt / EBITDA	1.31
Debt / FCF	2.43
Interest Coverage	8.62

Financial Efficiency

Return on equity (ROE) is 15.75% and return on invested capital (ROIC) is 9.95%.

Return on Equity (ROE)	15.75%
Return on Assets (ROA)	6.04%
Return on Invested Capital (ROIC)	9.95%
Return on Capital Employed (ROCE)	19.28%
Revenue Per Employee	1.11M
Profits Per Employee	41,784
Employee Count	348
Asset Turnover	1.63
Inventory Turnover	7.64

Taxes

In the past 12 months, Krynica Vitamin has paid 2.58 million in taxes.

Income Tax	2.58M
Effective Tax Rate	15.06%

Stock Price Statistics

The stock price has decreased by -0.50% in the last 52 weeks. The beta is -0.13, so Krynica Vitamin's price volatility has been lower than the market average.

Beta (5Y)	-0.13
52-Week Price Change	-0.50%
50-Day Moving Average	9.76
200-Day Moving Average	9.38
Relative Strength Index (RSI)	55.23
Average Volume (20 Days)	2,444

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Krynica Vitamin had revenue of PLN 386.55 million and earned 14.54 million in profits. Earnings per share was 1.19.

Revenue	386.55M
Gross Profit	68.16M
Operating Income	22.89M
Pretax Income	17.12M
Net Income	14.54M
EBITDA	36.92M
EBIT	22.89M
Earnings Per Share (EPS)	1.19

Balance Sheet

The company has 15.33 million in cash and 48.53 million in debt, giving a net cash position of -33.20 million or -2.71 per share.

Cash & Cash Equivalents	15.33M
Total Debt	48.53M
Net Cash	-33.20M
Net Cash Per Share	-2.71
Equity (Book Value)	97.96M
Book Value Per Share	8.00
Working Capital	-6.63M

Cash Flow

In the last 12 months, operating cash flow was 29.11 million and capital expenditures -9.16 million, giving a free cash flow of 19.95 million.

Operating Cash Flow	29.11M
Capital Expenditures	-9.16M
Free Cash Flow	19.95M
FCF Per Share	1.63

Margins

Gross margin is 17.63%, with operating and profit margins of 5.92% and 3.76%.

Gross Margin	17.63%
Operating Margin	5.92%
Pretax Margin	4.43%
Profit Margin	3.76%
EBITDA Margin	9.55%
EBIT Margin	5.92%
FCF Margin	5.16%

Dividends & Yields

This stock pays an annual dividend of 0.27, which amounts to a dividend yield of 2.70%.

Dividend Per Share	0.27
Dividend Yield	2.70%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	2.70%
Earnings Yield	11.87%
FCF Yield	16.28%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Krynica Vitamin has an Altman Z-Score of 2.47 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.47
Piotroski F-Score	7